Brief: Pieris Pharmaceuticals Says On August 30 Board Approved Retention Benefits For Retained Employees In Connection With Workplace Restructuring

Palvella Therapeutics

31/08/2023 23:10

Aug 31 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PIERIS PHARMACEUTICALS INC - ON AUGUST 30 BOARD APPROVED
RETENTION BENEFITS FOR RETAINED EMPLOYEES IN CONNECTION WITH
WORKPLACE RESTRUCTURING
    * PIERIS PHARMACEUTICALS-DUE TO RESTRUCTURING EXPECTS TO
INCUR
ESTIMATED RETENTION BENEFITS, SEVERANCE, RELATED COSTS OF ABOUT
$3.4 MILLION THROUGH Q2 2024

Source text for Eikon:  ID: 
Further company coverage:  PIRS.O 

 ((Reuters.Brief@thomsonreuters.com;))